- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Phase 3, safety study, [S,S]-Reboxetine, Fibromyalgia
Total 74262 results
-
Quoin PharmaceuticalsRecruitingNetherton SyndromeUnited States
-
AblynxCompletedRespiratory Syncytial Virus InfectionAustralia, Belgium, Bulgaria, Estonia, Hungary, Israel, Latvia, Malaysia, Philippines, Poland, Slovakia, Spain, Thailand, United Kingdom
-
Ataturk UniversityCompleted3rd Level Intensive Care UnitTurkey
-
Poitiers University HospitalActive, not recruitingSchatzker Type 2 or 3 Tibial Plateau FractureFrance, Martinique
-
Universitaire Ziekenhuizen KU LeuvenCompletedCondition of Patient 3 Years After FESS-operationBelgium
-
Thai Red Cross AIDS Research CentreActive, not recruiting
-
GeropharmCompletedBioequivalenceRussian Federation
-
Institut National de la Santé Et de la Recherche...MCM Vaccines B.V.CompletedImmunosuppression | Renal Transplant RecipientsFrance
-
Gdansk University of Physical Education and SportUniversity of Southampton; Medical University of GdanskCompletedEffect of Omega-3 Supplementation on Exercise Performance and Muscle Tissue FunctionsPoland
-
University of California, Los AngelesNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHuman Papillomavirus | CIN 3 | CIN 2United States
-
Seoul St. Mary's HospitalGenexine, Inc.UnknownCervical Intraepithelial Neoplasia 3Korea, Republic of
-
Indonesia UniversityRecruitingBurn Degree Second | Burn Degree ThirdIndonesia
-
Keck School of Medicine of USCNot yet recruiting
-
GeropharmCompleted
-
Autoimmune Technologies, LLCCompleted
-
Kathmandu University School of Medical SciencesNorwegian University of Science and TechnologyRecruitingUrinary IncontinenceNepal
-
Medical University of WarsawCompletedGestational Diabetes MellitusPoland
-
Cordis CorporationCompleted
-
Gilead SciencesCompleted
-
Centre Hospitalier Universitaire de NiceCompletedAdult Chronic Haemodialysis Patients Since at Least 3 MonthsFrance
-
Ligartis GmbHWithdrawn
-
Novartis PharmaceuticalsCompletedAtopic DermatitisGermany, Austria, France
-
Kortuc, Inc.Not yet recruitingCervical CancerIndia, Thailand, United Kingdom
-
Almirall, S.A.Completed
-
Sun Pharmaceutical Industries LimitedTerminatedActive Ankylosing Spondylitis or Non-Radiographic Axial SpondyloarthritisUnited States, Hungary, Poland, Spain
-
AfimmuneCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Cipla BioTec Pvt. Ltd.Quintiles, Inc.Unknown
-
OFFHEALTH S.p.A.Not yet recruiting
-
Apellis Pharmaceuticals, Inc.AvailableC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States
-
AblynxCompletedRheumatoid ArthritisCzechia, Bulgaria, Germany, Mexico, Poland, Romania, Serbia, Spain, Hungary, United States, Belgium, Georgia, Moldova, Republic of, North Macedonia
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States, Croatia, Serbia, Bulgaria, India, Korea, Republic of, Philippines, Romania, Russian Federation, Slovakia, Taiwan, Ukraine
-
Almirall, S.A.Completed
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.CompletedOsteoarthritis of the Knee or HipUnited States, Bulgaria, Chile, Colombia, Denmark, Estonia, Germany, Hong Kong, Hungary, Italy, Lithuania, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Sweden, Ukraine, United Kingdom
-
3-C Institute for Social DevelopmentCompleted
-
3-C Institute for Social DevelopmentCompletedSubstance-Related DisordersUnited States
-
Centre Oscar LambretUniversité Lille 3Completed
-
Catalyst Pharmaceuticals, Inc.TerminatedSpinal Muscular Atrophy Type 3Italy
-
Regeneron PharmaceuticalsSanofiCompletedHypercholesterolemiaUnited States, France, Italy, Germany, Spain, Canada, United Kingdom, Australia, Mexico
-
GeropharmCompletedBioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia)BioequivalenceRussian Federation
-
GeropharmCompletedBioequivalenceRussian Federation
-
Akebia TherapeuticsCompletedAnemia | Dialysis-Dependent Chronic Kidney DiseaseUnited States, Italy, Canada, Korea, Republic of, United Kingdom, Australia, Germany, Israel, France, Portugal, Bulgaria, Russian Federation, Ukraine, Poland, Brazil, Argentina, Mexico, Serbia
-
Linkoeping UniversityArmauer Hansen Research Institute, Ethiopia; University of GondarCompleted
-
Linkoeping UniversityKalmar County Hospital; University of GondarCompleted
-
Gilead SciencesCompletedHepatitis CUnited States, Australia, Canada, Puerto Rico, New Zealand, Sweden, Italy, Netherlands
-
University of North Carolina, Chapel Hill3-C Family ServicesCompleted
-
ASLAN PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Australia, Singapore
-
GeropharmCompletedPharmacokinetics | BioequivalenceRussian Federation
-
University Hospital, Strasbourg, FranceUnknown